The data highlight the possibility of SGLT 1/2 inhibitors having protective effects beyond heart failure and diabetes.
The following is a summary of “Glycemic and weight control in people with type 2 diabetes: A real-world observational study ...
9h
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback